RGNX · REGENXBIO Inc. Common Stock
View on chartInsiders & Stakes
| Kenneth T. Mills President and CEO | ▲ Buy | Grant | 495,925 Shares held | 5/29/2026 | View profile |
| Curran Simpson Chief Oper. & Tech. Officer | ▼ Sell | Tax Withholding | 338,053 Shares held | 7/1/2026 | View profile |
| Vasista Vittal Chief Financial Officer | ▲ Buy | Option Exercise | 246,534 Shares held | 3/19/2024 | View profile |
| Danos Olivier Chief Scientific Officer | ▼ Sell | Tax Withholding | 226,348 Shares held | 2/1/2025 | View profile |
| Patrick J. Christmas Chief Legal Officer | ▼ Sell | Tax Withholding | 205,968 Shares held | 8/1/2026 | View profile |
| Steve Pakola Chief Medical Officer | ▼ Sell | Tax Withholding | 205,541 Shares held | 8/1/2026 | View profile |
| Mitchell Chan Chief Financial Officer | ▼ Sell | Tax Withholding | 122,815 Shares held | 9/1/2026 | View profile |
| Gregory Austin Ciongoli | ▲ Buy | Open Market | 118,035 Shares held | 8/27/2026 | View profile |
| Craig Malzahn Chief Technology Officer | ▼ Sell | Tax Withholding | 81,960 Shares held | 9/1/2026 | View profile |
| Jennifer Zachary EVP, General Counsel | ▲ Buy | Grant | 31,871 Shares held | 5/29/2026 | View profile |
| Daniel Tasse CHIEF EXECUTIVE OFFICER | ▲ Buy | Grant | 28,861 Shares held | 5/29/2026 | View profile |
| Jean Bennett | ▲ Buy | Grant | 28,861 Shares held | 5/29/2026 | View profile |
| David C. Stump Director | ▲ Buy | Grant | 28,861 Shares held | 5/29/2026 | View profile |
| George Migausky V Director | ▲ Buy | Grant | 28,861 Shares held | 5/29/2026 | View profile |
| Argeris N. Karabelas Director | ▲ Buy | Grant | 28,861 Shares held | 5/29/2026 | View profile |
| Alexandra Glucksmann | ▲ Buy | Grant | 28,861 Shares held | 5/29/2026 | View profile |
| Allan M. Fox Director | ▲ Buy | Grant | 28,861 Shares held | 5/29/2026 | View profile |
Transaction History
| Craig Malzahn | ▼ Sell | Tax Withholding | 234 | $2K | 9/1/2026 |
| Mitchell Chan | ▼ Sell | Tax Withholding | 4,902 | $46K | 9/1/2026 |
| Gregory Austin Ciongoli | ▲ Buy | Open Market | 53,407 | $500K | 8/27/2026 |
| Gregory Austin Ciongoli | ▲ Buy | Open Market | 49,196 | $450K | 8/26/2026 |
| Gregory Austin Ciongoli | ▲ Buy | Grant | 15,432 | $0 | 8/25/2026 |
| Steve Pakola | ▼ Sell | Tax Withholding | 7,468 | $72K | 8/1/2026 |
| Patrick J. Christmas | ▼ Sell | Tax Withholding | 4,699 | $46K | 8/1/2026 |
| Steve Pakola | ▲ Buy | Option Exercise | 2,161 | $17K | 7/2/2026 |
| Steve Pakola | ▼ Sell | Open Market | 2,161 | $29K | 7/2/2026 |
| Curran Simpson | ▼ Sell | Tax Withholding | 6,818 | $89K | 7/1/2026 |
| Steve Pakola | ▲ Buy | Option Exercise | 36,725 | $289K | 7/1/2026 |
| Steve Pakola | ▼ Sell | Open Market | 36,725 | $472K | 7/1/2026 |
| Curran Simpson | ▲ Buy | Grant | 1,453 | $15K | 6/30/2026 |
| Steve Pakola | ▼ Sell | Open Market | 19,608 | $216K | 6/29/2026 |
| Allan M. Fox | ▲ Buy | Grant | 9,807 | $0 | 5/29/2026 |
| George Migausky V | ▲ Buy | Grant | 9,807 | $0 | 5/29/2026 |
| Daniel Tasse | ▲ Buy | Grant | 9,807 | $0 | 5/29/2026 |
| Argeris N. Karabelas | ▲ Buy | Grant | 9,807 | $0 | 5/29/2026 |
| Alexandra Glucksmann | ▲ Buy | Grant | 9,807 | $0 | 5/29/2026 |
| Kenneth T. Mills | ▲ Buy | Grant | 9,807 | $0 | 5/29/2026 |
| David C. Stump | ▲ Buy | Grant | 9,807 | $0 | 5/29/2026 |
| Jean Bennett | ▲ Buy | Grant | 9,807 | $0 | 5/29/2026 |
| Jennifer Zachary | ▲ Buy | Grant | 9,807 | $0 | 5/29/2026 |
| Steve Pakola | ▼ Sell | Open Market | 15,309 | $169K | 5/11/2026 |
| Steve Pakola | ▼ Sell | Open Market | 5,124 | $53K | 3/10/2026 |
| Patrick J. Christmas | ▼ Sell | Tax Withholding | 4,700 | $52K | 2/1/2026 |
| Steve Pakola | ▼ Sell | Tax Withholding | 5,267 | $59K | 2/1/2026 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 225,000 | $2.9M | 1/27/2026 |
| Kenneth T. Mills | ▼ Sell | Tax Withholding | 221,753 | $3.0M | 1/27/2026 |
| Steve Pakola | ▲ Buy | Grant | 65,847 | $0 | 1/6/2026 |
| Craig Malzahn | ▲ Buy | Grant | 65,847 | $0 | 1/6/2026 |
| Curran Simpson | ▲ Buy | Grant | 144,864 | $0 | 1/6/2026 |
| Patrick J. Christmas | ▲ Buy | Grant | 73,749 | $0 | 1/6/2026 |
| Mitchell Chan | ▲ Buy | Grant | 73,749 | $0 | 1/6/2026 |
| Curran Simpson | ▼ Sell | Tax Withholding | 18,559 | $267K | 1/2/2026 |
| Craig Malzahn | ▼ Sell | Tax Withholding | 1,238 | $18K | 1/2/2026 |
| Patrick J. Christmas | ▼ Sell | Tax Withholding | 9,793 | $141K | 1/2/2026 |
| Steve Pakola | ▼ Sell | Tax Withholding | 18,247 | $263K | 1/2/2026 |
| Curran Simpson | ▲ Buy | Grant | 951 | $7K | 12/31/2025 |
| Curran Simpson | ▼ Sell | Open Market | 20,811 | $263K | 10/9/2025 |
| Curran Simpson | ▼ Sell | Open Market | 7,624 | $76K | 9/29/2025 |
| Curran Simpson | ▼ Sell | Open Market | 7,734 | $77K | 9/10/2025 |
| Craig Malzahn | ▼ Sell | Tax Withholding | 234 | $2K | 9/1/2025 |
| Mitchell Chan | ▼ Sell | Tax Withholding | 4,901 | $44K | 9/1/2025 |
| Patrick J. Christmas | ▼ Sell | Tax Withholding | 4,699 | $38K | 8/1/2025 |
| Curran Simpson | ▼ Sell | Tax Withholding | 4,701 | $39K | 7/1/2025 |
| Allan M. Fox | ▲ Buy | Grant | 7,768 | $0 | 5/30/2025 |
| Jennifer Zachary | ▲ Buy | Grant | 7,768 | $0 | 5/30/2025 |
| David C. Stump | ▲ Buy | Grant | 7,768 | $0 | 5/30/2025 |
| Kenneth T. Mills | ▲ Buy | Grant | 7,768 | $0 | 5/30/2025 |
| Daniel Tasse | ▲ Buy | Grant | 7,768 | $0 | 5/30/2025 |
| George Migausky V | ▲ Buy | Grant | 7,768 | $0 | 5/30/2025 |
| Alexandra Glucksmann | ▲ Buy | Grant | 7,768 | $0 | 5/30/2025 |
| Argeris N. Karabelas | ▲ Buy | Grant | 7,768 | $0 | 5/30/2025 |
| Jean Bennett | ▲ Buy | Grant | 7,768 | $0 | 5/30/2025 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 20,602 | $77K | 5/12/2025 |
| Kenneth T. Mills | ▼ Sell | Open Market | 20,602 | $163K | 5/12/2025 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 30,752 | $116K | 3/27/2025 |
| Patrick J. Christmas | ▼ Sell | Tax Withholding | 4,700 | $38K | 2/1/2025 |
| Steve Pakola | ▼ Sell | Tax Withholding | 5,263 | $42K | 2/1/2025 |
| Danos Olivier | ▼ Sell | Tax Withholding | 5,452 | $44K | 2/1/2025 |
| Danos Olivier | ▼ Sell | Tax Withholding | 12,630 | $98K | 1/2/2025 |
| Curran Simpson | ▼ Sell | Tax Withholding | 11,917 | $92K | 1/2/2025 |
| Curran Simpson | ▲ Buy | Grant | 98,912 | $0 | 1/2/2025 |
| Patrick J. Christmas | ▼ Sell | Tax Withholding | 11,395 | $88K | 1/2/2025 |
| Danos Olivier | ▲ Buy | Grant | 59,347 | $0 | 1/2/2025 |
| Steve Pakola | ▼ Sell | Tax Withholding | 13,891 | $107K | 1/2/2025 |
| Steve Pakola | ▲ Buy | Grant | 64,293 | $0 | 1/2/2025 |
| Argeris N. Karabelas | ▲ Buy | Option Exercise | 10,000 | $38K | 10/1/2024 |
| Argeris N. Karabelas | ▼ Sell | Open Market | 10,000 | $101K | 10/1/2024 |
| Mitchell Chan | ▲ Buy | Grant | 58,869 | $0 | 9/16/2024 |
| Argeris N. Karabelas | ▲ Buy | Option Exercise | 10,000 | $38K | 9/3/2024 |
| Argeris N. Karabelas | ▼ Sell | Open Market | 9,300 | $107K | 9/3/2024 |
| Argeris N. Karabelas | ▼ Sell | Open Market | 700 | $9K | 9/3/2024 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 36,316 | $31K | 8/8/2024 |
| Argeris N. Karabelas | ▲ Buy | Option Exercise | 100 | $1K | 8/1/2024 |
| Curran Simpson | ▼ Sell | Open Market | 100 | $2K | 8/1/2024 |
| Argeris N. Karabelas | ▼ Sell | Open Market | 100 | $2K | 8/1/2024 |
| Steve Pakola | ▲ Buy | Grant | 58,386 | $0 | 8/1/2024 |
| Argeris N. Karabelas | ▲ Buy | Option Exercise | 10,000 | $38K | 8/1/2024 |
| Argeris N. Karabelas | ▼ Sell | Open Market | 9,600 | $129K | 8/1/2024 |
| Argeris N. Karabelas | ▼ Sell | Open Market | 400 | $6K | 8/1/2024 |
| Danos Olivier | ▲ Buy | Grant | 58,867 | $0 | 8/1/2024 |
| Patrick J. Christmas | ▲ Buy | Grant | 56,446 | $0 | 8/1/2024 |
| Argeris N. Karabelas | ▲ Buy | Option Exercise | 11,000 | $140K | 7/29/2024 |
| Argeris N. Karabelas | ▼ Sell | Open Market | 11,000 | $165K | 7/29/2024 |
| Curran Simpson | ▼ Sell | Open Market | 9,648 | $145K | 7/29/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 15,369 | $215K | 7/25/2024 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 15,369 | $58K | 7/25/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 12,221 | $168K | 7/24/2024 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 12,221 | $46K | 7/24/2024 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 2,210 | $8K | 7/17/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 2,210 | $30K | 7/17/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 200 | $3K | 7/16/2024 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 200 | $752 | 7/16/2024 |
| Argeris N. Karabelas | ▲ Buy | Option Exercise | 10,000 | $38K | 7/1/2024 |
| Argeris N. Karabelas | ▼ Sell | Open Market | 10,000 | $113K | 7/1/2024 |
| Curran Simpson | ▲ Buy | Grant | 56,458 | $0 | 7/1/2024 |
| Danos Olivier | ▲ Buy | Grant | 1,363 | $14K | 6/28/2024 |
| David C. Stump | ▲ Buy | Grant | 4,790 | $0 | 5/31/2024 |
| Alexandra Glucksmann | ▲ Buy | Grant | 4,790 | $0 | 5/31/2024 |
| George Migausky V | ▲ Buy | Grant | 4,790 | $0 | 5/31/2024 |
| Daniel Tasse | ▲ Buy | Grant | 4,790 | $0 | 5/31/2024 |
| Allan M. Fox | ▲ Buy | Grant | 4,790 | $0 | 5/31/2024 |
| Jennifer Zachary | ▲ Buy | Grant | 4,790 | $0 | 5/31/2024 |
| Jean Bennett | ▲ Buy | Grant | 4,790 | $0 | 5/31/2024 |
| Argeris N. Karabelas | ▲ Buy | Grant | 4,790 | $0 | 5/31/2024 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 15,000 | $56K | 5/14/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 15,000 | $237K | 5/14/2024 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 15,000 | $56K | 4/15/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 15,000 | $273K | 4/15/2024 |
| Vasista Vittal | ▲ Buy | Option Exercise | 20,041 | $75K | 3/19/2024 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 15,000 | $56K | 3/14/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 15,000 | $328K | 3/14/2024 |
| Steve Pakola | ▲ Buy | Option Exercise | 12,878 | $287K | 3/5/2024 |
| Steve Pakola | ▼ Sell | Open Market | 12,878 | $365K | 3/5/2024 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 15,000 | $56K | 2/14/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 4,652 | $77K | 2/14/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 10,348 | $175K | 2/14/2024 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 45,000 | $169K | 1/16/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 45,000 | $683K | 1/16/2024 |
| Steve Pakola | ▼ Sell | Open Market | 17,237 | $300K | 1/3/2024 |
| Steve Pakola | ▼ Sell | Tax Withholding | 10,385 | $186K | 1/2/2024 |
| Vasista Vittal | ▼ Sell | Tax Withholding | 4,534 | $81K | 1/2/2024 |
| Patrick J. Christmas | ▲ Buy | Grant | 34,615 | $0 | 1/2/2024 |
| Steve Pakola | ▲ Buy | Grant | 32,051 | $0 | 1/2/2024 |
| Danos Olivier | ▼ Sell | Tax Withholding | 8,410 | $151K | 1/2/2024 |
| Danos Olivier | ▲ Buy | Grant | 38,462 | $0 | 1/2/2024 |
| Curran Simpson | ▲ Buy | Grant | 38,462 | $0 | 1/2/2024 |
| Vasista Vittal | ▲ Buy | Grant | 16,026 | $0 | 1/2/2024 |
| Kenneth T. Mills | ▼ Sell | Tax Withholding | 11,357 | $204K | 1/2/2024 |
| Kenneth T. Mills | ▲ Buy | Grant | 64,103 | $0 | 1/2/2024 |
| Patrick J. Christmas | ▼ Sell | Tax Withholding | 7,893 | $142K | 1/2/2024 |
| Curran Simpson | ▼ Sell | Tax Withholding | 8,120 | $146K | 1/2/2024 |
| Kenneth T. Mills | ▼ Sell | Open Market | 45,000 | $886K | 12/19/2023 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 1,500 | $1K | 12/19/2023 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 43,500 | $164K | 12/19/2023 |
| Danos Olivier | ▲ Buy | Grant | 1,123 | $19K | 6/30/2023 |
| Jennifer Zachary | ▲ Buy | Grant | 3,486 | $0 | 6/2/2023 |
| Allan M. Fox | ▲ Buy | Grant | 3,486 | $0 | 6/2/2023 |
| Jean Bennett | ▲ Buy | Grant | 3,486 | $0 | 6/2/2023 |
| George Migausky V | ▲ Buy | Grant | 3,486 | $0 | 6/2/2023 |
| Alexandra Glucksmann | ▲ Buy | Grant | 3,486 | $0 | 6/2/2023 |
| Daniel Tasse | ▲ Buy | Grant | 3,486 | $0 | 6/2/2023 |
| Argeris N. Karabelas | ▲ Buy | Grant | 3,486 | $0 | 6/2/2023 |
| David C. Stump | ▲ Buy | Grant | 3,486 | $0 | 6/2/2023 |
| Vasista Vittal | ▲ Buy | Option Exercise | 35,000 | $30K | 5/31/2023 |
| Vasista Vittal | ▲ Buy | Grant | 46,174 | $0 | 1/3/2023 |
| Curran Simpson | ▼ Sell | Tax Withholding | 2,076 | $47K | 1/3/2023 |
| Vasista Vittal | ▼ Sell | Tax Withholding | 1,333 | $30K | 1/3/2023 |
| Steve Pakola | ▼ Sell | Open Market | 3,138 | $70K | 1/3/2023 |
| Steve Pakola | ▼ Sell | Tax Withholding | 1,837 | $42K | 1/3/2023 |
| Curran Simpson | ▲ Buy | Grant | 67,945 | $0 | 1/3/2023 |
| Danos Olivier | ▼ Sell | Tax Withholding | 2,058 | $47K | 1/3/2023 |
| Steve Pakola | ▲ Buy | Grant | 90,588 | $0 | 1/3/2023 |
| Danos Olivier | ▲ Buy | Grant | 65,930 | $0 | 1/3/2023 |
| Kenneth T. Mills | ▼ Sell | Tax Withholding | 9,308 | $211K | 1/3/2023 |
| Kenneth T. Mills | ▲ Buy | Grant | 54,753 | $0 | 1/3/2023 |
| Patrick J. Christmas | ▼ Sell | Tax Withholding | 1,843 | $42K | 1/3/2023 |
| Patrick J. Christmas | ▲ Buy | Grant | 67,940 | $0 | 1/3/2023 |
| Vasista Vittal | ▼ Sell | Open Market | 2,400 | $73K | 8/30/2022 |
| Vasista Vittal | ▼ Sell | Open Market | 17,280 | $608K | 8/5/2022 |
| Vasista Vittal | ▼ Sell | Open Market | 400 | $14K | 8/4/2022 |
| Vasista Vittal | ▼ Sell | Open Market | 2,400 | $75K | 8/1/2022 |
| Vasista Vittal | ▼ Sell | Open Market | 468 | $14K | 7/14/2022 |
| Vasista Vittal | ▼ Sell | Open Market | 4,332 | $130K | 7/13/2022 |
| Danos Olivier | ▲ Buy | Grant | 728 | $15K | 6/30/2022 |
| Jean Bennett | ▲ Buy | Grant | 3,010 | $0 | 6/3/2022 |
| Jennifer Zachary | ▲ Buy | Grant | 6,020 | $0 | 6/3/2022 |
| Daniel Tasse | ▲ Buy | Grant | 3,010 | $0 | 6/3/2022 |
| David C. Stump | ▲ Buy | Grant | 3,010 | $0 | 6/3/2022 |
| George Migausky V | ▲ Buy | Grant | 3,010 | $0 | 6/3/2022 |
| Argeris N. Karabelas | ▲ Buy | Grant | 3,010 | $0 | 6/3/2022 |
| Alexandra Glucksmann | ▲ Buy | Grant | 3,010 | $0 | 6/3/2022 |
| Allan M. Fox | ▲ Buy | Grant | 3,010 | $0 | 6/3/2022 |
| Vasista Vittal | ▲ Buy | Option Exercise | 29,900 | $25K | 1/20/2022 |
| Vasista Vittal | ▲ Buy | Grant | 8,900 | $0 | 1/3/2022 |
| Curran Simpson | ▲ Buy | Grant | 10,700 | $0 | 1/3/2022 |
| Steve Pakola | ▼ Sell | Open Market | 1,598 | $54K | 1/3/2022 |
| Steve Pakola | ▲ Buy | Grant | 8,900 | $0 | 1/3/2022 |
| Danos Olivier | ▲ Buy | Grant | 10,700 | $0 | 1/3/2022 |
| Patrick J. Christmas | ▲ Buy | Grant | 7,900 | $0 | 1/3/2022 |
| Kenneth T. Mills | ▲ Buy | Grant | 35,796 | $0 | 1/3/2022 |
| Curran Simpson | ▼ Sell | Tax Withholding | 1,332 | $44K | 1/1/2022 |
| Steve Pakola | ▼ Sell | Tax Withholding | 1,152 | $38K | 1/1/2022 |
| Danos Olivier | ▼ Sell | Tax Withholding | 1,221 | $40K | 1/1/2022 |
| Patrick J. Christmas | ▼ Sell | Tax Withholding | 1,332 | $44K | 1/1/2022 |
| Kenneth T. Mills | ▼ Sell | Tax Withholding | 3,636 | $119K | 1/1/2022 |
| Danos Olivier | ▲ Buy | Grant | 1 | $28 | 12/31/2021 |
| Allan M. Fox | ▼ Sell | Open Market | 44,908 | $1.6M | 12/23/2021 |
| Allan M. Fox | ▼ Sell | Open Market | 6,323 | $227K | 12/23/2021 |
| Allan M. Fox | ▼ Sell | Open Market | 61,638 | $2.1M | 12/22/2021 |
| Kenneth T. Mills | ▼ Sell | Gift | 3,300 | $0 | 12/2/2021 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 1,500 | $6K | 11/8/2021 |
| Kenneth T. Mills | ▼ Sell | Open Market | 1,500 | $60K | 11/8/2021 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 1,500 | $6K | 9/27/2021 |
| Kenneth T. Mills | ▼ Sell | Open Market | 1,500 | $63K | 9/27/2021 |
| Allan M. Fox | ▼ Sell | Open Market | 48,233 | $2.2M | 9/17/2021 |
| Kenneth T. Mills | ▲ Buy | Option Exercise | 33,146 | $125K | 9/14/2021 |
| Kenneth T. Mills | ▼ Sell | Open Market | 35,000 | $1.6M | 9/14/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
RGNX Reports Positive 3-Year Data and Settles Patent Litigation
RGNX presented three‑year data showing most NPDR patients improved by more than two steps on the DRSS, with no vision‑threatening events. The company also shared durability results for Surabgene Lomparvovec at the Retina Society meeting. In addition, RGNX settled all Elevidys patent disputes with Sarepta for $39 million and agreed to drop further litigation. These developments highlight progress in both clinical and legal fronts.
RGNX Reports Positive 3-Year Data and Settles Patent Litigation. RGNX presented three‑year data showing most NPDR patients improved by more than two steps on the DRSS, with no vision‑threatening events. The company also shared durability results for Surabgene Lomparvovec at the Retina Society meeting. In addition, RGNX settled all Elevidys patent disputes with Sarepta for $39 million and agreed to drop further litigation. These developments highlight progress in both clinical and legal fronts.